Clinical trial · Observational
Molecular Characterization of Primary Mucosal Melanoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary mucosal melanomas (MPM) are rarer than cutaneous melanomas, but also more severe. They are usually refractory to conventional approaches, regularly excluded from major therapeutic programs and not sensitive to new targeted therapies orphans. " The identification of therapeutic targets and accessibility to existing, developing or future targeted therapies improves the survival of patients with MPM. The principal goal is to describe, using a large panel of genes, the prevalence of major mutations in a cohort of MPMs based on the population of a French region.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mucosal Melanoma | Mucosal Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Somatic Genetic | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Mucosal melanoma
- description
- Incident Mucosal melanoma in the Champagne-Ardenne region 2004-2014
- interventionNames
- Genetic: Somatic Genetic
Primary outcomes (1)
- measure
- The frequency of main mutations identified using the NGS panel
- timeFrame
- Day 0
- description
- NGS panel
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * Incident Mucosal melanoma in the Champagne-Ardenne region 2004-2014 Exclusion criteria: * Cutaneous melanoma * Uveal melanoma
References
Publications (0)
Data not yet available